SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Felicia Cosman, Abaloparatide: a new anabolic therapy on the horizon, BoneKEy Reports, 2015, 4, 661

    CrossRef

  2. 2
    Sian Yik Lim, Marcy B. Bolster, Current approaches to osteoporosis treatment, Current Opinion in Rheumatology, 2015, 27, 3, 216

    CrossRef

  3. 3
    Jeffry S Nyman, Sasidhar Uppuganti, Alexander J Makowski, Barbara J Rowland, Alyssa R Merkel, Julie A Sterling, Todd L Bredbenner, Daniel S Perrien, Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysis, BoneKEy Reports, 2015, 4, 664

    CrossRef

  4. 4
    Chantal M.J. de Bakker, Allison R. Altman, Wei-Ju Tseng, Mary Beth Tribble, Connie Li, Abhishek Chandra, Ling Qin, X. Sherry Liu, μCT-based, in vivo dynamic bone histomorphometry allows 3D evaluation of the early responses of bone resorption and formation to PTH and alendronate combination therapy, Bone, 2015, 73, 198

    CrossRef

  5. 5
    Allison R. Altman, Wei-Ju Tseng, Chantal M.J. de Bakker, Beom Kang Huh, Abhishek Chandra, Ling Qin, X. Sherry Liu, A closer look at the immediate trabecula response to combined parathyroid hormone and alendronate treatment, Bone, 2014, 61, 149

    CrossRef

  6. 6
    Felicia Cosman, Anabolic and Antiresorptive Therapy for Osteoporosis: Combination and Sequential Approaches, Current Osteoporosis Reports, 2014, 12, 4, 385

    CrossRef

  7. 7
    Felicia Cosman, Combination therapy for osteoporosis: a reappraisal, BoneKEy Reports, 2014, 3,

    CrossRef

  8. 8
    Eric S. Orwoll, Jay Shapiro, Sandra Veith, Ying Wang, Jodi Lapidus, Chaim Vanek, Jan L. Reeder, Tony M. Keaveny, David C. Lee, Mary A. Mullins, Sandesh C.S. Nagamani, Brendan Lee, Evaluation of teriparatide treatment in adults with osteogenesis imperfecta, Journal of Clinical Investigation, 2014, 124, 2, 491

    CrossRef

  9. 9
    Erik F. Eriksen, Tony M. Keaveny, Eileen R. Gallagher, John H. Krege, Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis, Bone, 2014, 67, 246

    CrossRef

  10. 10
    Christian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, Imre Pavo, Judith Haschka, Wolfgang Schima, Stylianos Kapiotis, Heinrich Resch, Overlapping and Continued Alendronate or Raloxifene Administration in Patients on Teriparatide: Effects on Areal and Volumetric Bone Mineral Density—The CONFORS Study, Journal of Bone and Mineral Research, 2014, 29, 8
  11. 11
    J. H. Krege, N. E. Lane, J. M. Harris, P. D. Miller, PINP as a biological response marker during teriparatide treatment for osteoporosis, Osteoporosis International, 2014, 25, 9, 2159

    CrossRef

  12. 12
    Felicia Cosman, Is there a role for combination therapy for osteoporosis?, Endocrine, 2013, 44, 1, 5

    CrossRef

  13. 13
    Dennis M Black, Anne L Schafer, The search for the optimal anabolic osteoporosis therapy, Journal of Bone and Mineral Research, 2013, 28, 11